Patents Assigned to Laboratoires Delagrange (Synthelabo)
  • Method of providing anxiolytic and antipsychotic treatment
    Patent number: 5141949
    Abstract: Anxiolytic and antipsychotic treatment is provided to patients by administering therapeutically effective amounts of N-[2-(diethylamino)-ethyl]-2-methoxy-4-[(1-H-4,5-dihydro-2-imidazolyl)-ami no]-5-chlorobenzamide, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 31, 1991
    Date of Patent: August 25, 1992
    Assignee: Laboratoires Delagrange (Synthelabo)
    Inventors: Jacques Acher, Jean-Claude Monier, Jean-Paul Schmitt, Brenda Costall, Robert Naylor, Renee Gardaix-Luthereau